Allscripts (MDRX) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Allscripts (MDRX) PT Lowered to $17 at Cowen; Bookings Miss Likely Due to Timing
February 16, 2018 6:30 AM ESTCowen lowered its price target on Allscripts (NASDAQ: MDRX) to $17.00 (from $18.00) while maintaining a Outperform rating.
Analsyt Charles Rhyee commented, "MDRX reported 4Q results ahead of expectations, but bookings were softer than expected, likely due to timing in our view. We think the... More
